Category

investors

12 videos

Slack Capital interview: Damien Perriman, CCO (teaser)
investors
Slack Capital interview: Damien Perriman, CCO (teaser) May 21, 2025 · 77 views
Slack Capital interview: Tyler Korman, VP of Research
investors
Slack Capital interview: Tyler Korman, VP of Research May 19, 2025 · 73 views
eXoZymes launches subsidiary, NCTx, to unlock a promising compound for gut and liver health
investors
eXoZymes launches subsidiary, NCTx, to unlock a promising compound for gut and liver health May 06, 2025 · 259 views
AI transforming biotechnology: From form with AlphaFold to function with exozymes
investors
AI transforming biotechnology: From form with AlphaFold to function with exozymes April 28, 2025 · 298 views
Introducing our new CCO: Damien Perriman
investors
Introducing our new CCO: Damien Perriman April 02, 2025 · 154 views
Fox Business interview with CEO Michael Heltzen
investors
Fox Business interview with CEO Michael Heltzen March 13, 2025 · 121 views
CNBC closing bell footage from Feb 19, 2025
investors
CNBC closing bell footage from Feb 19, 2025 February 21, 2025 · 35 views
Nasdaq: The full eXoZymes closing bell ceremony from Feb 19, 2025
investors
Nasdaq: The full eXoZymes closing bell ceremony from Feb 19, 2025 February 20, 2025 · 164 views
Nasdaq: eXoZymes CEO Michael Heltzen's closing bell speech
investors
Nasdaq: eXoZymes CEO Michael Heltzen's closing bell speech February 20, 2025 · 103 views
Looking at the rest of 2025 - part 4 of a fireside chat about Invizyne
investors
Looking at the rest of 2025 - part 4 of a fireside chat about Invizyne February 11, 2025 · 126 views
Go To Market Strategy - part 3 of a fireside chat about Invizyne
investors
Go To Market Strategy - part 3 of a fireside chat about Invizyne January 15, 2025 · 178 views
Using AI for Enzyme Engineering - part 2 of a fireside chat about Invizyne
investors
Using AI for Enzyme Engineering - part 2 of a fireside chat about Invizyne January 07, 2025 · 264 views